Understand how clinics reference epitalon within longevity research and anti-aging contexts. Compare provider positioning and supervision standards. This page is informational and does not diagnose, prescribe, or recommend therapies.
Looking for clinics by city? Explore peptide clinics in Miami , Los Angeles, and New York to compare verified providers by treatment focus.
Recovery peptide users often compare BPC-157 and TB-500, while metabolic health users usually cross-reference semaglutide.
People researching Epitalon are usually exploring longevity, anti-aging, or sleep, and have often seen strong telomerase or life-extension claims online. Good clinics explain that those claims come mainly from older Russian, animal, and cell-culture research, that it is not an approved medicine, and that any use is experimental and should be discussed with a licensed clinician.
This page is useful for people comparing longevity, anti-aging, or wellness clinics that reference Epitalon, and for anyone trying to separate the headline telomerase and longevity claims from what the human evidence actually supports.
Epitalon pricing varies widely and is often folded into a longevity or wellness package rather than billed as a standalone medicine. Because it is unapproved and under-evidenced in humans, compare the clinical oversight, monitoring, and sourcing transparency a clinic includes rather than the headline cost — a lower price with no supervision is not a saving.
Epitalon (Epithalon / Epithalamin) is a synthetic tetrapeptide, Ala-Glu-Asp-Gly, developed by Vladimir Khavinson and colleagues at the St. Petersburg Institute of Bioregulation and Gerontology in Russia. Its sequence was derived from Epithalamin, a peptide extract of the pineal gland, and it is most often discussed in longevity, anti-aging, and sleep contexts. It is not an approved medicine in either the UK or US: the FDA has not approved any Epitalon product, and in the UK the MHRA would treat any medicinal use as unlicensed. It is generally sold as a 'research chemical' marked 'for research use only', and on clinic directories it tends to appear in longevity, anti-aging, and wellness-clinic settings rather than mainstream medical care.
Epitalon is described as acting on the pineal gland and the telomerase system: proposed mechanisms include stimulating melatonin production, helping normalise age-related circadian and neuroendocrine changes, and activating telomerase (the enzyme that maintains telomeres) in some cells. The most cited finding is that, in cultured human cells, Epitalon appeared to reactivate telomerase and extend telomere length — a result from single-laboratory and, more recently, one independent in-vitro replication, not from completed human trials. Honestly framed, much of this evidence is preclinical (cell and animal studies) and originates largely from one research group, so claims of slowed aging or extended lifespan in people remain preliminary and unproven. For someone comparing clinics, the key question is whether a provider presents this mechanism as theory supported by limited evidence rather than as established fact.
Epitalon is generally inexpensive as a raw 'research chemical', but in a clinic setting it is usually bundled into broader longevity, anti-aging, or wellness programmes alongside consultations, testing, and other interventions. Because it is unapproved and the human evidence is limited, the value to compare is the quality of clinical oversight, sourcing transparency, and the honesty of how benefits are described — not the headline price. See the peptide therapy cost guide.
Reported short-term tolerability in the available studies has generally been described as favourable, but the human safety evidence is limited, much of it is preclinical, and long-term safety in people is not well established. Because Epitalon is not an approved medicine, anyone considering it should do so only with a licensed clinician who can explain the evidence limits, sourcing, and risks. This page is informational only — it does not diagnose, prescribe, recommend Epitalon, or provide dosing or administration guidance.
Compare this with semaglutide vs tirzepatide or move into city pages such as Los Angeles and New York if you want to compare how providers frame these treatments locally.
Epitalon is not an approved medicine in the UK or US. The FDA has not approved any Epitalon product, and in the UK the MHRA would treat medicinal use as unlicensed. It is typically sold as a 'research chemical' labelled 'for research use only' rather than as a regulated treatment.
The telomerase and longevity claims come mainly from older Russian studies, animal work, and cell-culture experiments — largely from a single research group, with one recent independent in-vitro replication. There are no robust completed human trials showing it slows aging or extends lifespan, so these benefits remain preliminary and unproven.
Epitalon and Epithalon are spellings of the same synthetic tetrapeptide (Ala-Glu-Asp-Gly). Epithalamin is the original pineal-gland peptide extract its sequence was based on; the terms are often used loosely but refer to closely related compounds.
Because Epitalon is not approved for human therapeutic use, it would generally fall under WADA's S0 'non-approved substances' category, which is prohibited at all times. Athletes in tested sport should always confirm against the current WADA prohibited list before using anything.
Short-term tolerability in the available studies has generally been described as favourable, but the human safety evidence is limited and long-term safety in people is not well established. As an unapproved substance, it should only be considered with a licensed clinician who can explain the risks and evidence limits.
No. Peptide Clinic Finder is an informational directory. We do not sell Epitalon, provide medical advice, or recommend its use — we help you compare how clinics position and supervise treatments so you can make an informed decision with a licensed clinician.
Related comparisons: NAD+ vs Epitalon, GHK-Cu vs Epitalon.
Next step
If you are considering this treatment, compare providers, review your options, and choose the path that best fits your goals and preferred level of care.
Move from peptide research into clinic comparisons, guides, and matching.
Not sure whether local clinics or online options are the better fit? compare providers or use our matching tool to find the right next step. If you want a broader market view first, find a peptide clinic near you.
Move from treatment research into provider comparison by choosing the next step that fits your buying journey. Some users want to compare programmes first, while others want a faster route into matched options or local clinic discovery.
Next step
Move from peptide research into real provider comparison by checking city pages, cost context, and related treatment comparisons. Clinics vary more by oversight and programme structure than by peptide name alone.
For clinics
Get featured on this page and reach patients actively looking for peptide therapy, GLP-1 treatments, recovery support, and longevity care.